Skip to main content

Table 4 The minimum, maximum and average biologically equivalent doses (BED) to organs at risk for investigated treatment plans.

From: MRS-guided HDR brachytherapy boost to the dominant intraprostatic lesion in high risk localised prostate cancer

    

HDR brachytherapy

 

EBRT, 74Gy

rectum

urethra

 

rectum

RtFemH&N

LtFemH&N

10Gy HDR

brachytherapy

SIB HDR

brachytherapy

10Gy HDR

brachytherapy

SIB HDR

brachytherapy

BEDmin, Gy

18.09

0.11

1.43

0.97

0.83

31.99

24.34

BEDmax, Gy

123.92

82.99

75.80

105.34

62.24

82.67

62.00

BEDav, Gy

77.97

19.55

36.81

6.33

5.37

58.30

42.8